REED'S, INC.
REEDNYSEConsumer Staples · Bottled & Canned Soft Drinks & Carbonated Waters · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $34.1M | $38.0M | $44.7M | $53.0M | $49.6M | $41.6M |
| Operating income | −$15.1M | −$8.1M | −$9.4M | −$14.8M | −$16.0M | −$8.6M |
| Net income | −$15.8M | −$13.2M | −$15.5M | −$20.1M | −$16.4M | −$10.2M |
| Total assets | $23.3M | $25.1M | $18.9M | $25.5M | $26.3M | $20.1M |
| Total liabilities | $14.2M | $18.5M | $38.1M | $34.0M | $22.1M | $9.7M |
| Equity | $9.2M | $6.6M | −$19.2M | −$8.5M | $4.2M | $10.4M |
| EPS (diluted) | $-1.91 | $-1.64 | $-4.39 | $-9.07 | $-8.99 | — |
| Shares out. | 45.4M | 4.2M | 2.6M | 112.8M | 86.4M | 47.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −44.5%
- Net margin
- −46.5%
- Return on equity
- −173.1%
- Return on assets
- −67.9%
- Return on capital (ROCE)
- −152.2%
- Liabilities / assets
- 60.8%
- Debt / equity
- 1.55×
- Book value / share
- $0.20
- Revenue growth (YoY)
- −10.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -24.84distress
- Accruals / assets
- 5.1%moderate
- Beneish M-Score
- -2.58normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 0 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 16, 2024
- NT 10-Qmissed a reporting deadline ↗May 16, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
- NT 10-Qmissed a reporting deadline ↗May 12, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Era Regenerative Medicine LtdActivist (13D)Jun 11, 2025
- Whitebox Advisors LlcPassive (13G)Feb 14, 2025
- Deng ShufenActivist (13D)Jan 31, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 23,127 | 1.0 | +27.7% |
| Apr 30, 2026 | 18,109 | 1.0 | -36.3% |
| Apr 15, 2026 | 28,415 | 2.1 | -1.5% |
| Mar 31, 2026 | 28,844 | 1.0 | +20.6% |
| Mar 13, 2026 | 23,908 | 1.0 | +244.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 12, 2026
- Director / officer change · Regulation FD disclosureApr 24, 2026
- Director / officer changeApr 17, 2026
- Other material eventApr 8, 2026
- Director / officer changeMar 27, 2026
- Results of operationsMar 24, 2026
- Director / officer change · Regulation FD disclosureDec 29, 2025
- Amended charter or bylaws · Other material eventDec 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.